February 01, 2013

Drug allocation during a shortage

What criteria are used at facilities to determine which patients receive drugs during an extreme drug shortage when only a limited supply is available within the facility? How is this issue communicated to patients, if at all?

Ponatinib (Iclusig), bosutinib (Bosulif), and omacetaxine (Synribo) are enhancing treatment for persons with certain forms of leukemia.